Novo Nordisk's GLP-1 drugs have been under considerable competitive pressure in the last few months, so the company will be ...

Less than a year after it was forced to withdraw GBT's sickle cell disease (SCD) therapy Oxbryta from all world markets after ...

In another sign of increased regulatory scrutiny of vaccines in the US, Health and Human Services (HHS) Secretary Robert F ...

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...

Researchers from MIT have used generative AI (genAI) algorithms to design novel antibiotics that can treat two 'superbugs' – ...

“Sexuality and intimacy are important aspects of quality of life and may also reduce some of the psychosocial distress ...

Regulatory agencies are offering more flexibility when it comes to viral clearance strategies, but this must be aligned with ...

Confirmation of that has come in the form of an update (PDF) from the New Jersey Department of Labour and Workforce ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease ...

Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...